SAHA SAURABH — SEC Form 4 filings
SEC reporting owner CIK 1861926. 28 Form 4 filings on record with FilingPulse; latest filed 2026-05-15.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2024-02-02 to 2026-05-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 58,275 shares, $254,079 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 27 legs across 18 filings — 977,646 shares, $15,261,194 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 175,000 shares @ $16.52 ($2,891,822) in Centessa Pharmaceuticals plc, filed 2024-09-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer, Director | 23 | — | 26 legs · 960,000 sh · $15,142,084 | 27 |
| CLARIVATE PLC (CLVT) | Director | 5 | 1 leg · 58,275 sh · $254,079 | 1 leg · 17,646 sh · $119,110 | 6 |
Form 4 filings — SAHA SAURABH
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-15 | 4 | CLARIVATE PLC (CLVT) | Tax withholding (F): 8,178 @ $2.44 · Grant/award (A): 62,264 @ $0 | EDGAR |
| 2025-07-21 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 55,000 @ $3.85 · Sale (S): 55,000 @ $15.92 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 55,000 @ $3.85 · Sale (S): 55,000 @ $12.63 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 55,000 @ $3.85 · Sale (S): 55,000 @ $12.71 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | CLARIVATE PLC (CLVT) | Tax withholding (F): 4,974 @ $4.17 · Grant/award (A): 39,473 @ $0 | EDGAR |
| 2025-04-22 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 14,656 @ $12.29 · Sale (S): 40,344 @ $12.43 | EDGAR |
| 2025-03-21 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 55,000 @ $16.69 | EDGAR |
| 2025-03-05 | 4 | CLARIVATE PLC (CLVT) | Purchase (P): 58,275 @ $4.36 | EDGAR |
| 2025-02-20 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 54,225 @ $15.92 · Sale (S): 775 @ $16.54 | EDGAR |
| 2025-02-04 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 43,381 @ $16.92 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 53,375 @ $15.76 · Sale (S): 1,625 @ $16.19 | EDGAR |
| 2024-12-31 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 36,263 @ $16.35 | EDGAR |
| 2024-12-20 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 55,000 @ $17.44 | EDGAR |
| 2024-12-06 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 87,496 @ $5.84 · Sale (S): 87,496 @ $18.46 · Option exercise (M): 87,496 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 299 @ $5.84 · Sale (S): 299 @ $18.23 · Option exercise (M): 299 (derivative) @ $0 | EDGAR |
| 2024-11-22 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 55,000 @ $16.89 · Option exercise (M): 3,511 @ $5.84 · Sale (S): 3,511 @ $18.24 · Option exercise (M): 1,671 @ $5.84 · Sale (S): 1,671 @ $18.24 · Option exercise (M): 3,511 (derivative) @ $0 · +1 more | EDGAR |
| 2024-11-15 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 32,023 @ $5.84 · Sale (S): 32,023 @ $18.28 · Option exercise (M): 32,023 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 22,205 @ $15.80 · Sale (S): 30,203 @ $15.67 · Sale (S): 2,592 @ $15.32 | EDGAR |
| 2024-10-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 36,263 @ $15.79 | EDGAR |
| 2024-09-20 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 55,000 @ $16.53 | EDGAR |
| 2024-09-12 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 175,000 @ $5.84 · Sale (S): 175,000 @ $16.52 · Option exercise (M): 175,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | CLARIVATE PLC (CLVT) | Sale (S): 17,646 @ $6.75 | EDGAR |
| 2024-08-23 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 46,651 @ $12.30 | EDGAR |
| 2024-08-22 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 4,169 @ $12.32 · Sale (S): 3,674 @ $12.25 · Sale (S): 506 @ $12.23 | EDGAR |
| 2024-07-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 36,263 @ $9.03 | EDGAR |
| 2024-05-08 | 4 | CLARIVATE PLC (CLVT) | Tax withholding (F): 4,412 @ $7.05 · Grant/award (A): 23,741 @ $0 | EDGAR |
| 2024-04-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 36,263 @ $11.30 | EDGAR |
| 2024-02-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Grant/award (A): 144,200 @ $0 · Tax withholding (F): 26,323 @ $8.19 · Grant/award (A): 576,800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861926 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →